Therefore, a sensible detection technique such as Qp9 or a mechanism enhancing the signal intensity such as heme oxygenase-1 blocker, iron chelating agents or PpIX transporter protein blocker may possibly be combined in the future for more sensible detection of different fluorescenting GBM or maybe even lower grade glioma. This evidence concerns the gene HMOX1 and glioma.